Peptide compound for inhibiting restenosis and promoting re-endothelialization and method for preparing the same
US9603891B2 · kind B2 · utility
4Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 2015 |
| Grant date | Mar 28, 2017 |
| Priority date | — |
| Expiry date | Jun 17, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2420/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are a peptide compound prepared by additional synthesis in a drug having an effect of inhibiting restenosis, a composition for inhibiting restenosis and promoting re-endothelialization including the peptide compound, and a stent having a surface coated by using the composition, in order to overcome a restenosis problem in the stent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.